These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 32538242)

  • 1. Metabolomics markers in Neurology: current knowledge and future perspectives for therapeutic targeting.
    Bonomo R; Cavaletti G; Skene DJ
    Expert Rev Neurother; 2020 Jul; 20(7):725-738. PubMed ID: 32538242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances in metabolomics in neurological disease, and future perspectives.
    Zhang AH; Sun H; Wang XJ
    Anal Bioanal Chem; 2013 Oct; 405(25):8143-50. PubMed ID: 23715678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiomics tools for the diagnosis and treatment of rare neurological disease.
    Crowther LM; Poms M; Plecko B
    J Inherit Metab Dis; 2018 May; 41(3):425-434. PubMed ID: 29536202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolomics: moving to the clinic.
    Nordström A; Lewensohn R
    J Neuroimmune Pharmacol; 2010 Mar; 5(1):4-17. PubMed ID: 19399626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of metabolomics in neurological disease.
    Hassan-Smith G; Wallace GR; Douglas MR; Sinclair AJ
    J Neuroimmunol; 2012 Jul; 248(1-2):48-52. PubMed ID: 22341863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent advances and perspectives of metabolomics-based investigations in Parkinson's disease.
    Shao Y; Le W
    Mol Neurodegener; 2019 Jan; 14(1):3. PubMed ID: 30634989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging Metabolomics Biomarkers of Polycystic Ovarian Syndrome; Targeting the Master Metabolic Disrupters for Diagnosis and Treatment.
    Omabe M; Elom S; Omabe KN
    Endocr Metab Immune Disord Drug Targets; 2018; 18(3):221-229. PubMed ID: 29359679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolomics: a novel approach to identify potential diagnostic biomarkers and pathogenesis in Alzheimer's disease.
    Xu XH; Huang Y; Wang G; Chen SD
    Neurosci Bull; 2012 Oct; 28(5):641-8. PubMed ID: 23054640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Untargeted metabolomics: an overview of its usefulness and future potential in prenatal diagnosis.
    Parfieniuk E; Zbucka-Kretowska M; Ciborowski M; Kretowski A; Barbas C
    Expert Rev Proteomics; 2018 Oct; 15(10):809-816. PubMed ID: 30239246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolomic insights into pathophysiological mechanisms and biomarker discovery in clear cell renal cell carcinoma.
    Lucarelli G; Loizzo D; Franzin R; Battaglia S; Ferro M; Cantiello F; Castellano G; Bettocchi C; Ditonno P; Battaglia M
    Expert Rev Mol Diagn; 2019 May; 19(5):397-407. PubMed ID: 30983433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mass spectrometry strategies for clinical metabolomics and lipidomics in psychiatry, neurology, and neuro-oncology.
    Wood PL
    Neuropsychopharmacology; 2014 Jan; 39(1):24-33. PubMed ID: 23842599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical neuroproteomics and biomarkers: from basic research to clinical decision making.
    Shoemaker LD; Achrol AS; Sethu P; Steinberg GK; Chang SD
    Neurosurgery; 2012 Mar; 70(3):518-25. PubMed ID: 21866062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolomics of neural progenitor cells: a novel approach to biomarker discovery.
    Maletić-Savatić M; Vingara LK; Manganas LN; Li Y; Zhang S; Sierra A; Hazel R; Smith D; Wagshul ME; Henn F; Krupp L; Enikolopov G; Benveniste H; Djurić PM; Pelczer I
    Cold Spring Harb Symp Quant Biol; 2008; 73():389-401. PubMed ID: 19022759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolomics: a global biochemical approach to the study of central nervous system diseases.
    Kaddurah-Daouk R; Krishnan KR
    Neuropsychopharmacology; 2009 Jan; 34(1):173-86. PubMed ID: 18843269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The metabolomic signature of hematologic malignancies.
    Allegra A; Innao V; Gerace D; Bianco O; Musolino C
    Leuk Res; 2016 Oct; 49():22-35. PubMed ID: 27526405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolomics in pediatric nephrology: emerging concepts.
    Hanna MH; Brophy PD
    Pediatr Nephrol; 2015 Jun; 30(6):881-7. PubMed ID: 25027575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advances in mass spectrometry imaging for multiomics application in neurology.
    Xu G; Li J
    J Comp Neurol; 2019 Sep; 527(13):2158-2169. PubMed ID: 30393860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Network-based strategies in metabolomics data analysis and interpretation: from molecular networking to biological interpretation.
    Perez De Souza L; Alseekh S; Brotman Y; Fernie AR
    Expert Rev Proteomics; 2020 Apr; 17(4):243-255. PubMed ID: 32380880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mass spectrometry-based metabolomics: applications to biomarker and metabolic pathway research.
    Zhang A; Sun H; Yan G; Wang P; Wang X
    Biomed Chromatogr; 2016 Jan; 30(1):7-12. PubMed ID: 25739660
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.